Daniel Mori-Fegan HBSc
Daniel Mori-Fegan is a PhD Candidate at the University of Toronto (UofT) in the Department of Pharmacology and Toxicology. He graduated from UofT’s undergraduate program as a double specialist in Pharmacology and Toxicology. He is currently co-supervised by Dr. Ruth Ross of the Department of Pharmacology and Toxicology, as well as Dr. Walter Swardfager of the Sunnybrook Research Institute. Currently, his research focuses on the orphan G-protein coupled receptor, GPR55, which is described as an atypical cannabinoid receptor and its relationship to Alzheimer’s Disease (AD) phenotypes. Specifically, he is interested in GPR55’s interplay with AD biomarkers, brain neurodegeneration and cognitive ability. His research experience ranges from cellular work, imaging, animal behaviour studies and most recently, clinical data analysis utilising longitudinal data gathered from the Alzheimer’s Disease Neuroimaging Initiative.
University:
University of Toronto
Principal Faculty:
Faculty of Medicine
Principal Department/Program:
Pharmacology and Toxicology
Principal Hospital Appointment:
Sunnybrook Health Science Centre
Supervisor:
Dr Ruth Ross
Key Publications:
NA